ANTIRETROVIRAL KOMBINATIONSBEHANDLING in English translation

• combination antiretroviral therapy
• combination antiretroviral treatment

Examples of using Antiretroviral kombinationsbehandling in Danish and their translations into English

især ved samtidig anvendelse af kolesterolsænkende medicin og antiretroviral kombinationsbehandling, herunder med proteasehæmmere og nukleosidanaloger.
particularly when taking medicines to lower cholesterol in combination with antiretroviral therapy, including protease inhibitors and nucleoside analogues.

Udvalget for Humanmedicinske Lægemidler(CHMP) konkluderede, at fordelene ved Combivir opvejer risiciene ved antiretroviral kombinationsbehandling af hiv- infektion.
The Committee for Medicinal Products for Human Use(CHMP) decided that Combivir' s benefits are greater than its risks in antiretroviral combination therapy for the treatment of HIV infection.

Patienter bør orienteres om, at Kivexa eller anden antiretroviral kombinationsbehandling ikke helbreder HIV- infektion og at der fortsat kan udvikles opportunistiske infektioner
Opportunistic infections: patients should be advised that Kivexa or any other antiretroviral therapy does not cure HIV infection and that they may still develop opportunistic infections

Immunreaktiveringssyndrom Hos HIV- inficerede patienter med svær immuninsufficiens kan der ved påbegyndelseaf antiretroviral kombinationsbehandling(CART) opstå en inflammatorisk reaktion på asymptomatiske
In HIV-infected patients with severe immune deficiency at the time of initiation of combination antiretroviral therapy(CART), an inflammatory reaction to asymptomatic or residual opportunistic infections

Immunreaktiveringssyndrom Hos HIV- inficerede patienter med svær immuninsufficiens på tidspunktet for påbegyndelse af antiretroviral kombinationsbehandling(CART) kan der opstå en inflammatorisk reaktion på asymptomatiske
Immune reactivation syndrome In HIV infected patients with severe immune deficiency at the time of institution of combination antiretroviral therapy(CART), an inflammatory reaction to asymptomatic

Nogle af de patienter, der får antiretroviral kombinationsbehandling.
Some patients taking combination antiretroviral therapy may develop a.

Åndedrætsbesvær rødmen(udvidelse af blodkar) forandringer i fedtfordelingen se Bivirkninger forbundet med antiretroviral kombinationsbehandling nedenfor.
Difficulty in breathing flushing of the skin(vasodilation) changes in fat distribution see Side effects associated with combination antiretroviral therapy below.

metaboliske forstyrrelser Antiretroviral kombinationsbehandling er blevet forbundet med omfordeling af kropsfedt(lipodystrofi) hos HIV- inficerede patienter.
metabolic disorders Combination antiretroviral therapy has been associated with redistribution of body fat(lipodystrophy) in HIV infected patients.

Antiretroviral kombinationsbehandling kan også forårsage forhøjet mælkesyre
Combination antiretroviral therapy may also cause raised lactic acid

Udvalget for Humanmedicinske Lægemidler(CHMP) konkluderede, at fordelene ved Norvir opvejer risiciene ved antiretroviral kombinationsbehandling af hiv1- inficerede patienter.
The Committee for Medicinal Products for Human Use(CHMP) decided that Norvir' s benefits are greater than its risks in combination with other antiretroviral agents for the treatment of HIV-1 infected patients.

fremskreden HIV- sygdom eller langtidseksponering for antiretroviral kombinationsbehandling CART.
advanced HIV disease or long-term exposure to combination antiretroviral therapy CART.

avanceret HIV- sygdom eller langtidsbehandling med antiretroviral kombinationsbehandling CART.
advanced HIV disease or long-term exposure to combination antiretroviral therapy CART.

Hos HIV- inficerede patienter med svær immuninsufficiens kan der ved påbegyndelse af antiretroviral kombinationsbehandling(CART) opstå en inflammatorisk reaktion på.
In HIV infected patients with severe immune deficiency at the time of institution of combination antiretroviral therapy(CART), an inflammatory reaction to asymptomatic or residual opportunistic pathogens may arise and cause serious clinical conditions, or aggravation of symptoms.

som behandles med antiretroviral kombinationsbehandling, har øget risiko for svære
C and treated with combination antiretroviral therapy are at an increased risk for severe

Antiretroviral kombinationsbehandling kan også give øget mælkesyre
Combination antiretroviral therapy may also cause raised lactic acid

Antiretroviral kombinationsbehandling kan også forårsage en øget mængde mælkesyre
Combination antiretroviral therapy may also cause raised lactic acid

langvarig eksponering for antiretroviral kombinationsbehandling CART.
long-term exposure to combination antiretroviral therapy CART.

Patienter med før- eksisterende leverfunktionssvigt inklusiv kronisk aktiv hepatitis har en højere risiko for leverfunktions abnormaliteter under antiretroviral kombinationsbehandling og bør monitoreres ifølge standard i praksis.
Patients with pre-existing liver dysfunction including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.

Patienter med præeksisterende leverdysfunktion, herunder kronisk hepatitis, har en øget forekomst af unormal leverfunktion under antiretroviral kombinationsbehandling, og de skal monitoreres i henhold til standardpraksis.
Patients with pre-existing liver dysfunction including chronic hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.

Nogle af de patienter, der får antiretroviral kombinationsbehandling, kan udvikle en knoglesygdom, der kaldes knoglenekrose hvor knoglevævet dør på grund af nedsat blodtilførsel til knoglen.
Some patients taking combination antiretroviral therapy may develop a bone disease called osteonecrosis death of bone tissue caused by loss of blood supply to the bone.